Ingram Robert Alexander
SEC-identified person · CIK 1219890 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Biocryst Pharmaceuticals INC BCRX | Director | filed 2015–2023 |
| Black Diamond Therapeutics, Inc. BDTX | Director | filed 2020–2022 |
| Novan, Inc. NOVN | Director | filed 2016–2020 |
| Phasebio Pharmaceuticals Inc PHAS | Officer | filed 2018–2018 |
| Wolfspeed, INC. WOLF | Director | filed 2008–2018 |
| G1 Therapeutics, Inc. GTHX | Officer | filed 2017–2018 |
| Valeant Pharmaceuticals International, Inc. vrx | Director | filed 2010–2017 |
| Clearside Biomedical, Inc. CLSD | Officer | filed 2016–2017 |
| Regeneron Pharmaceuticals, INC. REGN | Director | filed 2014–2015 |
| Edwards Lifesciences Corp ew | Director | filed 2006–2015 |
| Allergan INC AGN | Director | filed 2006–2012 |
| Pharmaceutical Product Development INC PPDI | Director | filed 2011–2011 |
| Lowes Companies INC LOW | Director | filed 2006–2011 |
| Valeant Pharmaceuticals International VRX | Director | filed 2006–2010 |
| OSI Pharmaceuticals INC OSIP | Director | filed 2006–2010 |
| Wachovia Corp NEW WB | Director | filed 2006–2009 |
| Nortel Networks Corp NT | Director | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.